Brian J. Blaser is the President and CEO of QuidelOrtho Corporation, where he has been steering the ship since May 2024. He has a strong background in the medical field, previously serving as Executive Vice President at Abbott Laboratories, leading...

Current Market Cap

$2.58B

Number of Employees

7.1K

Total Compensation

2022 - 2023

Trending down by -31.61% last year
Showing total compensation for the last 2022 - 2023

Stock

Up by 0.00% last year

Salary

Down by -39.41% last year

Bonus

Down by -87.78% last year

Other

Up by 0.00% last year

Year

2023

Total Compensation

$1.96M

Salary

$621.00K

Board Justification

The compensation philosophy is designed to attract, retain, and motivate high-quality executives, aligning their interests with those of stockholders through a pay-for-performance approach.

Bonus

$225.00K

Board Justification

The bonus is based on the achievement of corporate performance goals under the 2023 Cash Incentive Plan, which includes revenue and Adjusted EBITDA targets.

Other

$24.93K

Board Justification

Includes expense reimbursements and other personal benefits.

Restricted Stock

$1.09M(14.78K RSU)

Board Justification

The time-based RSUs granted in 2023 vest over a three-year period, with one-third vesting each year on the anniversary of the grant date.

Performance Metrics

The performance metrics for determining the compensation include revenue targets and Adjusted EBITDA targets.

SEC Filing

From April 2, 2024

Brian J. Blaser

CEO of QuidelOrtho Corporation

Q

Education

Field of Expertise

Born

Invalid Date - 0 years ago

Is Founder?

No

Current Tenure

0 years 6 months (May 2024 - Present)

Previous Experience

Unknown